October 23, 2013
Feature Articles
Opportunities and Resources
- Lead the Inner City Asthma Consortium
- An R01 Funding Opportunity for HIV Researchers
- Opportunities to Explore Global Health Research
In The News
Advice Corner
- Reader Questions
- May an M.D. apply for NRSA for Individual Postdoctoral Fellows (F32)?
- Is there an NIAID-specific announcement for the NRSA Institutional Research Training Grants (T32) or should I use the parent announcement?
New Funding Opportunities
Post-Shutdown Updates and Web Resources
The government shutdown earlier this month has severely affected applications and reviews, delaying due dates and forcing NIH to reschedule over 200 peer review meetings.
NIH is still grappling with the impact, and guidance is fluid. However, we can share some late-breaking information.
As of this newsletter's publication, applications reviewed by the Center for Scientific Review (CSR) that were originally scheduled for January Council will proceed as planned, meaning we will not have to delay funding decisions. NIH had previously issued a Guide notice moving those applications to May Council.
And, if you've already submitted an application for an October submission deadline, you will have the opportunity to replace the submission with a “refreshed” application. Note: Replacing the application submission with a "refreshed" application does not count as a resubmission.
It is still quite likely that some applications will need to be reassigned to May Council, but we hope those will be relatively few. NIH's Office of Extramural Research (OER) will notify applicants by email of any reassignments and of the option to submit a “refreshed” application.
For all funding opportunities affected by the shutdown, we have updated our NIAID Funding Opportunities List with new deadlines.
If you're expecting your award in November, you may have to wait a few extra days at most. NIH anticipates beginning to release awards shortly after November 1.
We will continue to update all pages of the Research Funding site with information as it becomes available.
To keep up with the latest news, follow the NIH resources listed below.
- Resuming Extramural Activities after the 2013 Government Shutdown
- Frequently Asked Questions: Resuming Extramural Operations After the Shutdown
- NIH Guide
- Funding Opportunities and Notices
- Here is a list of notices related to the shutdown:
- Revised Guidance on Resumption of NIH Extramural Activities Following the Recent Lapse in Appropriations
- Interim Guidance on Resumption of NIH Extramural Activities
- Update on the NIH RPPR Phase II Pilot Training Webinar for Demonstration Partnership Members
- Funding Opportunities and Notices
- eRA Commons' Get Connected list-servs
- NIH's Grants and Funding
- Rock Talk
Newsletter Publication Schedule
Read below for the issue of the NIAID Funding Newsletter we had scheduled to publish on October 2. It could not be published at that time due to the government shutdown.
We plan to return to a regular publication schedule as soon as possible, hopefully in time for our November 6 issue.
Lead the Inner City Asthma Consortium
For over 20 years, NIAID has supported research to reduce the burden of asthma among inner-city residents. This longstanding commitment continues with a funding opportunity announcement (FOA) for the Inner City Asthma Consortium (ICAC), one of the Institute's ongoing Research Programs on Asthma in the Inner City.
If you're interested in responding to this FOA, you should be able to lead ICAC and help meet its research objectives, which include:
- Developing allergen immunotherapy modalities to mitigate and/or prevent the effects of inner-city specific allergens on asthma.
- Developing and implementing clinical trials to prevent the incidence or progression of inner-city asthma.
- Investigating the pathogenesis and mechanisms of specific inner-city asthma phenotypes.
Studies should focus on children and adolescents under the age of 18 who live in U.S. inner cities. You must submit four sample clinical trials and three sample mechanistic studies. Trial and mechanistic study sites must meet requirements outlined in the FOA.
Optional letters of intent are due by November 20, 2013. The application deadline is December 20, 2013.
For complete details, including application instructions, read the August 26, 2013, Guide notice.
An R01 Funding Opportunity for HIV Researchers
With a recent funding opportunity announcement (FOA), NIAID seeks high-risk research on developing sustained release of antivirals for treating or preventing HIV infection.
You may propose products that are delivered using sustained release platforms, e.g., oral, injection, implant, or direct delivery to HIV target mucosa, that will provide a minimum of one week (for treatment) or one month (for prevention) of efficacy or protection.
We encourage you to specify milestones and timelines for your research, which may focus on one or more of the following topics for NIAID:
- Development of sustained release formulations for:
- HIV treatment with the potential for administering once a week or less frequently.
- HIV prevention with the potential for administering once a month or less frequently.
- Studies that incorporate investigating the pharmacology of the proposed formulations in animals to confirm that delivery systems are providing effective drug levels in plasma and target tissues (e.g., gastrointestinal, vaginal, central nervous system, cerebrospinal fluid, semen, lymph nodes).
- Projects that include assessing attributes (e.g., product application volume, location of application site, cold chain requirements) of proposed formulations.
Note that NIAID is not seeking development of new intravaginal rings (IVR) for sustained release.
The first of three due dates is January 7, 2014.
Find more information on the FOA in the September 11, 2013, Guide notice.
Opportunities to Explore Global Health Research
If you’re interested in working on global health issues, consider applying for a Grand Challenges Explorations
grant from Grand Challenges in Global Health supported by the Bill & Melinda Gates Foundation.This round of Grand Challenges Explorations focuses on the following topics:
- Inciting Healthy Behaviors: Nudge, Disrupt, Leapfrog, Reach
- New Enabling Tools and Models Supporting Development of Interventions for Enteric Dysfunction
- Innovations in Feedback and Accountability Systems for Agricultural Development
- The "One Health" Concept: Bringing Together Human and Animal Health for New Solutions
- Develop the Next Generation of Condom
Initial grants will be $100,000, and grantees on promising projects will have the opportunity to receive additional funding of up to $1 million. Proposals are due on November 12, 2013. For more information and application instructions, see Grand Challenges Explorations Round 12
.
Fellowship, Training, and Career Award Applications Switch to Forms-C in 2014
As we reported in our July 3, 2013, article "You Should 'C' Which SF 424 Forms to Use", electronic applications are transitioning to SF 424 version “C.” If you are applying for a fellowship, training, or career opportunity, note that these programs will make the switch to version C for due dates on or after January 25, 2014.
If you are working on an application for the February 2014 receipt date, make sure you go back to the funding opportunity announcement 45-60 days before the application deadline to get the Forms-C package.
For more information, refer to Do I Have The Right Electronic Forms for My Application?
News Briefs
Opportunity for Small Business Contract Solicitation. The 2014 Omnibus NIH/CDC Small Business Innovation Research (SBIR) Contract solicitation is now open, with a receipt date of November 13, 2013. For details, see the August 28, 2013, Guide notice.
Heads Up: PEPFAR-Related Supplements Coming Soon. In collaboration with the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR), NIH will publish an administrative supplement announcement for HIV/AIDS implementation science in PEPFAR settings. NIH will offer these supplements annually; the first call for applications should be out soon. For additional details, read the September 9, 2013, Guide notice.
Feel free to send us a question at deaweb@niaid.nih.gov. After responding to you, we may include your question in the newsletter, incorporate it into the NIAID Research Funding site, or both.
NIAID does not prohibit candidates with an M.D. degree from applying for an F32. See Support by Career Stage—M.D. Track and Advice on Research Training and Career Awards for more information.
"Is there an NIAID-specific announcement for NRSA Institutional Research Training Grants (T32) or should I use the parent announcement?"—anonymous reader
There is no NIAID-specific T32 announcement so yes, you should use NRSA Institutional Research Training Grants (Parent T32).
Keep in mind, though, that NIAID has its own submission deadlines: September 25 for non-AIDS applications and January 7 for AIDS-related applications.
For more information on the T32, see NIAID's Training Grants portal.
- PAR-13-364, Development of Assays for High-Throughput Screening for Use in Probe and Pretherapeutic Discovery
- RFP-NIAID-DAIDS-NIHAI2013172, In Vitro Testing Resource for HIV Therapeutics and Topical Microbicides
- PAR-13-358, Opportunities for Collaborative Research at the NIH Clinical Center
- PAR-13-357, Preapplication: Opportunities for Collaborative Research at the NIH Clinical Center
See other announcements at NIAID Funding Opportunities List.
.png)
No hay comentarios:
Publicar un comentario